SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2107448

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2107448

Asia Pacific CRISPR and Synthetic Biology Market, By Product Type and Services, By Technique, By Application, By End User, By Geography

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Asia Pacific CRISPR and Synthetic Biology Market is estimated to be valued at USD 6,839.9 Mn in 2026 and is expected to reach USD 35,932.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 26.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 6,839.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 26.70% 2033 Value Projection: USD 35,932.0 Mn

The Asia Pacific CRISPR and synthetic biology market is becoming one of the most rapidly expanding sectors of the biotechnology industry. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a revolutionary gene-editing technology, and synthetic biology, the engineering of new biological systems, are both driving innovation and significant investments in the Asia Pacific region. CRISPR enables targeted edits of the DNA in organisms to make them healthier, more resilient, and more productive.

While, synthetic biology is focused on building entirely new biology using an engineering-based approach to create novel bio-products, applications and processes that can improve life, in a number of applications including agriculture, human health and industrial biotechnology. China, Japan, South Korea, India and Australia are making considerable investment in genomics infrastructure, research and a wide array of biotechnology applications. Combined with the increase in the uptake of precision medicine, government-backed initiatives, and the growing academic-industry partnerships taking place across the region, the Asia Pacific market for CRISPR and synthetic biology technology products and services is anticipated to experience considerable expansion.

Market Dynamics

The Asia Pacific CRISPR and synthetic biology market is primarily driven by the rising demand for genomics and gene editing research, significant increase in government funding, and rising need of precision medicine. Also, China's National Key R&D program, Indian BIRAC programs supporting CRISPR and synthetic biology development are the key drivers of the industry growth. Moreover, increasing use of these techniques in cancer, genetic diseases, agriculture, and biomanufacturing are the leading factors for the growth of Asia Pacific CRISPR and synthetic biology market.

However, the growth of the market is limited by factors such as ethical issues in the field of CRISPR technology, the complexities in regulations, the price of the technology, and the patenting strategies in the CRISPR & synthetic biology. Nevertheless, there are abundant growth prospects due to factors such as rise in applications in crop development, increased emphasis on food safety, development in next-generation treatments in healthcare.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Asia Pacific CRISPR and synthetic biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, GenScript Biotech Corporation, Integrated DNA Technologies, Inc., Twist Bioscience Corporation, New England Biolabs, Inc., Illumina, Inc., BGI Group, Takara Bio Inc., and Ginkgo Bioworks Holdings, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Asia Pacific CRISPR and synthetic biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Asia Pacific CRISPR and synthetic biology market

Market Segmentation

  • Product Type and Services Insights (Revenue, USD Mn, 2021 - 2033)
  • Products
  • Services and Platform
  • Technique Insights (Revenue, USD Mn, 2021 - 2033)
  • Synthetic Biology
  • CRISPR
  • Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Therapeutic Applications
  • Diagnostics Applications
  • Industrial Application
  • Environmental Applications
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs) and CDMO's
  • Agriculture Industry
  • Chemical Industry
  • Clinical Laboratories
  • Others
  • Country Insights (Revenue, USD Mn, 2021 - 2033)
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Indonesia
  • Singapore
  • Vietnam
  • Philippines
  • Malaysia
  • Rest of Asia Pacific
  • Key Players Insights
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • Twist Bioscience Corporation
  • New England Biolabs, Inc.
  • Illumina, Inc.
  • BGI Group
  • Takara Bio Inc.
  • Ginkgo Bioworks Holdings, Inc.
Product Code: CMI9779

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Asia Pacific CRISPR and Synthetic Biology Market, By Product Type and Services
    • Asia Pacific CRISPR and Synthetic Biology Market, By Technique
    • Asia Pacific CRISPR and Synthetic Biology Market, By Application
    • Asia Pacific CRISPR and Synthetic Biology Market, By End User
    • Asia Pacific CRISPR and Synthetic Biology Market, By Country

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Asia Pacific CRISPR and Synthetic Biology Market, By Product Type and Services, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Services and Platform
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Asia Pacific CRISPR and Synthetic Biology Market, By Technique, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Synthetic Biology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • CRISPR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Asia Pacific CRISPR and Synthetic Biology Market, By Application, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Therapeutic Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Diagnostics Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Industrial Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Environmental Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Asia Pacific CRISPR and Synthetic Biology Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Contract Research Organizations (CROs) and CDMO's
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Agriculture Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Chemical Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Clinical Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Asia Pacific CRISPR and Synthetic Biology Market, By Country, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Country Trends
  • China
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • Japan
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • India
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • South Korea
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • Australia
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • Thailand
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • Indonesia
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • Singapore
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • Vietnam
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • Philippines
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • Malaysia
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)
  • Rest of Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type and Services, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, End User, 2021 - 2033, Value (USD Mn)

9. Competitive Landscape

  • Company Profile
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GenScript Biotech Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Integrated DNA Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Twist Bioscience Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • New England Biolabs, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Illumina, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • BGI Group
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takara Bio Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ginkgo Bioworks Holdings, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!